Stocks QURT Financial statements
Financial statementsQuarta-Rad, Inc. financial statements
Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Quarta-Rad, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.83 | 1.21 | 0.91 | 0.88 | 0.86 | 1.25 | 1.1 | 0.51 | 0.11 | 0.24 |
| Cost of revenue | 0.71 | 0.89 | 0.67 | 0.65 | 0.65 | |||||
| Gross profit | 0.12 | 0.32 | 0.23 | 0.23 | 0.21 | 0.48 | 0.4 | 0.18 | 0.04 | 0.1 |
| Research and development | 0 | 0.06 | 0.1 | 0.07 | ||||||
| General and administrative | 0.01 | 0.02 | 0.06 | 0.13 | 0.01 | 0.04 | 0.05 | 0.03 | 0.14 | 0.3 |
| Operating expenses | 0.16 | 0.23 | 0.33 | 0.37 | 0.19 | 0.36 | 0.26 | 0.2 | 0.25 | 0.39 |
| Operating income | 0.12 | 0.14 | -0.01 | -0.21 | -0.29 | |||||
| Pre-tax income | -0.04 | 0.09 | -0.1 | -0.14 | 0.02 | 0.01 | 0.02 | 0.06 | -0.18 | -0.25 |
| Income tax | -0.05 | 0.01 | 0 | 0.01 | 0.03 | 0 | ||||
| Net income | -0.04 | 0.09 | -0.1 | -0.14 | 0.08 | 0.01 | 0.01 | 0.04 | -0.22 | -0.26 |
| EBITDA | 0.12 | 0.14 | -0.01 | -0.21 | -0.29 | |||||
| EPS, basic | 0.00 | 0.01 | -0.01 | -0.01 | -0.01 | -0.02 | ||||
| EPS, diluted | 0.00 | 0.01 | -0.01 | -0.01 | -0.01 | -0.02 | ||||
| Shares, basic (weighted) | 15.1 | 15.3 | 15.3 | 15.3 | 15.3 | 15.7 | 15.7 | 15.7 | 15.7 | 15.9 |
| Shares, diluted (weighted) | 15.1 | 15.3 | 15.3 | 15.3 | 15.3 | 15.7 | 15.7 | 15.7 | 15.7 | 15.9 |
Balance sheet
| FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 0.07 | 0.08 | 0.09 | 0.04 | 0.11 | 0.26 | 0.29 | 0.07 | 0.06 | 0.07 |
| Short-term investments | 0.13 | 0.17 | 0.05 | 0 | 0 | |||||
| Receivables | 0.05 | 0.04 | 0.08 | 0.13 | 0.05 | 0.07 | 0.06 | 0.01 | 0.01 | |
| Inventory | 0.08 | 0.16 | 0.09 | 0.08 | 0.09 | 0.09 | 0.19 | 0.03 | 0 | |
| Other current assets | 0.02 | |||||||||
| Total current assets | 0.2 | 0.28 | 0.27 | 0.24 | 0.58 | 0.54 | 0.72 | 0.24 | 0.14 | 0.07 |
| Property, plant and equipment | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| Total assets | 0.2 | 0.28 | 0.27 | 0.24 | 0.63 | 0.58 | 0.75 | 0.68 | 0.58 | 0.41 |
| Accounts payable | 0 | 0.02 | 0.01 | 0.13 | 0.08 | 0.08 | 0.08 | 0.11 | 0.13 | 0.13 |
| Deferred revenue | 0.19 | |||||||||
| Total current liabilities | 0.08 | 0.27 | 0.32 | 0.25 | 0.4 | 0.29 | 0.4 | 0.29 | ||
| Total liabilities | 0.08 | 0.07 | 0.16 | 0.27 | 0.32 | 0.25 | 0.4 | 0.29 | 0.4 | 0.29 |
| Paid-in capital | 0.07 | 0.07 | 0.07 | 0.07 | 0.34 | 0.35 | 0.35 | 0.35 | 0.35 | 0.55 |
| Retained earnings | 0.06 | 0.14 | 0.05 | -0.1 | -0.02 | -0.01 | 0 | 0.05 | -0.17 | -0.43 |
| Shareholders' equity | 0.12 | 0.21 | 0.11 | -0.03 | 0.32 | 0.33 | 0.35 | 0.39 | 0.18 | 0.12 |
| Total equity | 0.12 | 0.21 | 0.11 | -0.03 | 0.32 | 0.33 | 0.35 | 0.39 | 0.18 | 0.12 |
| Total liabilities and equity | 0.2 | 0.28 | 0.27 | 0.24 | 0.63 | 0.58 | 0.75 | 0.68 | 0.58 | 0.41 |
| Shares outstanding | 15.3 | 15.3 | 15.3 | 15.3 | 15.7 | 15.7 | 15.7 | 15.7 | 15.7 | 15.9 |
Cash flow statement
| FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income | -0.04 | 0.09 | -0.1 | -0.14 | 0.02 | 0.12 | 0.01 | 0.04 | -0.22 | -0.26 |
| Depreciation and amortization | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| Stock-based compensation | 0.2 | |||||||||
| Deferred income tax | -0.05 | 0.01 | 0 | 0.01 | 0.03 | 0 | ||||
| Change in receivables | -0 | 0.01 | -0.05 | -0.04 | 0.08 | -0.02 | 0 | 0.03 | 0.01 | 0.01 |
| Change in inventory | 0.03 | -0.08 | 0.08 | 0.01 | -0.01 | 0 | -0.1 | 0.16 | 0.03 | 0 |
| Change in payables | -0 | 0.02 | -0.01 | 0.11 | -0.06 | -0.06 | 0 | 0.02 | 0.02 | 0.04 |
| Cash from operations | -0.06 | 0.01 | 0.01 | -0.05 | 0.04 | 0.05 | 0.2 | 0.05 | -0.08 | 0.01 |
| Capital expenditures | -0.45 | -0.52 | -0.58 | -0.66 | -0.47 | 0 | 0 | |||
| Purchases of investments | -0.43 | -0.43 | -0.06 | |||||||
| Sales and maturities of investments | 0.53 | 0.26 | 0.2 | 0.04 | ||||||
| Cash from investing | 0.03 | 0.1 | -0.17 | -0.27 | 0.07 | |||||
| Stock issued | 0.06 | 0.01 | ||||||||
| Cash from financing | 0.06 | 0.01 | ||||||||
| Net change in cash | 0 | 0.01 | 0.01 | -0.05 | 0.07 | 0.15 | 0.03 | -0.22 | -0.01 | 0.01 |
| Free cash flow | -0.44 | -0.56 | -0.55 | -0.61 | -0.27 | 0.05 | -0.08 | |||
| Interest paid | 0 | |||||||||
| Income taxes paid | 0.07 | 0.01 | 0 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 39.3% | Gross profit / revenue. |
| Operating margin | -102.4% | Operating income / revenue. |
| Pre-tax margin | -103.9% | Pre-tax income / revenue. |
| Net margin | -105.1% | Net income / revenue. |
| Operating cash flow margin | 3.8% | Cash from operations / revenue. |
| Return on equity (ROE) | -6,898.0% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | -67.1% | Net income / average total assets. |
| Stock-based pay / revenue | 55.4% | Stock-based compensation (from the cash flow statement) / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | 129.4% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | -39.4% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | -22.2% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Gross profit growth, 1y | 156.1% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | -36.5% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit CAGR, 5y | -13.7% | Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating cash flow CAGR, 3y | -63.3% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow CAGR, 5y | -23.0% | Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Book value growth, 1y | -29.9% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | -29.2% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value CAGR, 5y | -17.2% | Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Total assets growth, 1y | -28.4% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | -18.1% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | -8.2% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Share count change, 1y | 1.3% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | 0.4% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 5y | 0.7% | Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 0.15x | Current assets / current liabilities. |
| Quick ratio | 0.11x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 0.11x | (Cash + short-term investments) / current liabilities. |
| Liabilities / assets | 99.0% | Total liabilities / total assets. |
| Working capital | -$309.0K | Current assets - current liabilities. |
| Tangible book value | $3.6K | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.64x | Revenue / average total assets. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | -$0.02 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| Revenue per share | $0.01 | Revenue / diluted weighted shares. |
| Operating cash flow per share | $0.00 | Cash from operations / diluted weighted shares. |
| Book value per share | $0.00 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | $0.00 | Tangible book value / shares outstanding. |
| Cash per share | $0.00 | (Cash + short-term investments) / shares outstanding. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $5.6M | Share price x shares outstanding. |
| Enterprise value | $5.5M | Market cap + total debt - cash - short-term investments. |
| P/S | 23.7x | Market cap / revenue. |
| P/B | 1,558x | Market cap / shareholders' equity. Only when equity is positive. |
| Price / tangible book | 1,558x | Market cap / tangible book value, when positive. |
| P/OCF | 621x | Market cap / cash from operations, when positive. |
| EV/Sales | 23.6x | Enterprise value / revenue. |
| Earnings yield | -4.4% | Net income / market cap (the inverse of P/E). |
What was Quarta-Rad, Inc.'s revenue in fiscal 2025?
Quarta-Rad, Inc. reported revenue of $245.0K for fiscal 2025, 129.4% higher than the year before.
Was Quarta-Rad, Inc. profitable in fiscal 2025?
No. It reported a net loss of $256.9K.